GlaxoSmithKline reported GBP20.77B in Current Assets for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Alcon AG ALC:SW USD 5.19B 30M
Amgen AMGN:US USD 22.19B 1.88B
Artemis Alpha ATS:LN GBP 5.63M 4.38M
AstraZeneca AZN:LN USD 22.59B 2.37B
Bayer BAYN:GR EUR 37.76B 652M
Biogen BIIB:US USD 9.79B 25.4M
Fresenius FRE:GR EUR 18.28B 1.16B
Galapagos GLPG:NA EUR 4.24B 225.55M
Genmab GEN:DC DKK 28.38B 362M
Gilead Sciences GILD:US USD 15.23B 1.67B
GlaxoSmithKline GSK:LN GBP 20.77B 520M
Glaxosmithkline GSK:US GBP 20.77B 520M
Hikma Pharmaceutical HIK:LN USD 2B 145M
Lonza Group LONN:SW CHF 5.72B 13M
Merck MRK:GR EUR 12.2B 742M
Novartis NOVN:VX USD 36.91B 44M
Orion ORNBV:FH EUR 878.7M 800K
Recordati REC:IM EUR 1.24B 20.7M
Regeneron Pharmaceuticals REGN:US USD 22.06B 6.64B
Roche Holding ROG:VX 33.82B 3.5B
Smith & Nephew PLC SN/:LN 3.76B 665M